Analysis of shared heritability in common disorders of the brain
…, M Hrafnsdottir, JJ Hottenga, B Penninx, V Artto… - Science, 2018 - science.org
INTRODUCTION Brain disorders may exhibit shared symptoms and substantial epidemiological
comorbidity, inciting debate about their etiologic overlap. However, detailed study of …
comorbidity, inciting debate about their etiologic overlap. However, detailed study of …
Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine
…, JJ Hottenga, BWJH Penninx, M Färkkilä, V Artto… - Nature …, 2016 - nature.com
Migraine is a debilitating neurological disorder affecting around one in seven people worldwide,
but its molecular mechanisms remain poorly understood. There is some debate about …
but its molecular mechanisms remain poorly understood. There is some debate about …
Genome-wide meta-analysis identifies new susceptibility loci for migraine
…, DA Lawlor, DM Evans, SM Ring, M Färkkilä, V Artto… - Nature …, 2013 - nature.com
Migraine is the most common brain disorder, affecting approximately 14% of the adult
population, but its molecular mechanisms are poorly understood. We report the results of a meta-…
population, but its molecular mechanisms are poorly understood. We report the results of a meta-…
Genome-wide association analysis identifies susceptibility loci for migraine without aura
Migraine without aura is the most common form of migraine, characterized by recurrent
disabling headache and associated autonomic symptoms. To identify common genetic variants …
disabling headache and associated autonomic symptoms. To identify common genetic variants …
[HTML][HTML] Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles
Migraine affects over a billion individuals worldwide but its genetic underpinning remains
largely unknown. Here, we performed a genome-wide association study of 102,084 migraine …
largely unknown. Here, we performed a genome-wide association study of 102,084 migraine …
Off-label thrombolysis is not associated with poor outcome in patients with stroke
Background and Purpose— Numerous contraindications included in the license of alteplase,
most of which are not based on scientific evidence, restrict the portion of patients with acute …
most of which are not based on scientific evidence, restrict the portion of patients with acute …
Safety of thrombolysis in stroke mimics: results from a multicenter cohort study
…, H Gensicke, PA Lyrer, PA Ringleb, V Artto… - Stroke, 2013 - Am Heart Assoc
Background and Purpose— Intravenous thrombolysis for acute ischemic stroke is beneficial
within 4.5 hours of symptom onset, but the effect rapidly decreases over time, necessitating …
within 4.5 hours of symptom onset, but the effect rapidly decreases over time, necessitating …
Recurrent ischemic events in young adults after first‐ever ischemic stroke
…, E Haapaniemi, AJ Metso, TM Metso, V Artto… - Annals of …, 2010 - Wiley Online Library
Objective:: Data on recurrence of vascular events and their prognostic factors in young (<50
years of age) stroke patients are not well defined. Methods:: We assessed the occurrence of …
years of age) stroke patients are not well defined. Methods:: We assessed the occurrence of …
Premonitory symptoms in migraine: a cross-sectional study in 2714 persons
K Laurell, V Artto, L Bendtsen, K Hagen… - …, 2016 - journals.sagepub.com
Aim To describe the frequency and number of premonitory symptoms (PS) in migraine, the
co-occurrence of different PS, and their association with migraine-related factors. Methods In …
co-occurrence of different PS, and their association with migraine-related factors. Methods In …
Outcome by stroke etiology in patients receiving thrombolytic treatment: descriptive subtype analysis
…, J Putaala, V Viitanen, S Curtze, S Atula, V Artto… - Stroke, 2011 - Am Heart Assoc
Background and Purpose— Treating ischemic stroke with thrombolytic therapy is effective and
safe, but limited data exist on its efficacy and safety in different etiologic subtypes. Methods…
safe, but limited data exist on its efficacy and safety in different etiologic subtypes. Methods…